You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/17553
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRodrigues de Almeida Costa, Celso A.-
dc.contributor.authorKohn, Daniele Oliveira-
dc.contributor.authorde Lima, Valeria Martins-
dc.contributor.authorGargano, Andre Costa-
dc.contributor.authorFlorio, Jorge Camilo-
dc.contributor.authorCosta, Mirtes-
dc.date.accessioned2014-05-20T13:49:18Z-
dc.date.available2014-05-20T13:49:18Z-
dc.date.issued2011-09-01-
dc.identifierhttp://dx.doi.org/10.1016/j.jep.2011.07.003-
dc.identifier.citationJournal of Ethnopharmacology. Clare: Elsevier B.V., v. 137, n. 1, p. 828-836, 2011.-
dc.identifier.issn0378-8741-
dc.identifier.urihttp://hdl.handle.net/11449/17553-
dc.description.abstractEthnopharmacological relevance: The essential oil (EO) from Cymbopogon citratus (DC) Stapf is reported to have a wide range of biological activities and is widely used in traditional medicine as an infusion or decoction. However, despite this widely use, there are few controlled studies confirming its biological activity in central nervous system.Materials and methods: The anxiolytic-like activity of the EO was investigated in light/dark box (LDB) and marble-burying test (MBT) and the antidepressant activity was investigated in forced-swimming test (FST) in mice. Flumazenil, a competitive antagonist of benzodiazepine binding and the selective 5-HT1A receptor antagonist WAY100635 was used in experimental procedures to determine the action mechanism of EO. To exclude any false positive results in experimental procedures, mice were submitted to the rota-rod test. We also quantified some neurotransmitters at specific brain regions after EO oral acute treatment.Results: The present work found anxiolytic-like activity of the EO at the dose of 10 mg/kg in a LDB. Flumazenil, but not WAY100635, was able to reverse the effect of the EO in the LOB, indicating that the EO activity occurs via the GABA(A) receptor-benzodiazepine complex. Only at higher doses did the EO potentiate diethyl-ether-induced sleeping time in mice. In the FST and MBT, EO showed no effect. Finally, the increase in time spent in the light chamber, demonstrated by concomitant treatment with ineffective doses of diazepam (DZP) and the EO, revealed a synergistic effect of the two compounds. The lack of activity after long-term treatment in the LDB test might be related to tolerance induction, even in the DZP-treated group. Furthermore, there were no significant differences between groups after either acute or repeated treatments with the EO in the rota-rod test. Neurochemical evaluation showed no amendments in neurotransmitter levels evaluated in cortex, striatum, pons, and hypothalamus.Conclusions: The results corroborate the use of Cymbopogon citratus in folk medicine and suggest that the anxiolytic-like effect of its EO is mediated by the GABA(A) receptor-benzodiazepine complex. (C) 2011 Elsevier B.V. All rights reserved.en
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)-
dc.format.extent828-836-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.sourceWeb of Science-
dc.subjectAnxiolyticen
dc.subjectCymbopogon citratusen
dc.subjectEssential oilen
dc.subjectGABAergic systemen
dc.subjectLemongrassen
dc.subjectSedativeen
dc.titleThe GABAergic system contributes to the anxiolytic-like effect of essential oil from Cymbopogon citratus (lemongrass)en
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.description.affiliationUNESP Univ Estadual Paulista, Inst Biosci, Dept Pharmacol, BR-18618970 São Paulo, Brazil-
dc.description.affiliationUniv São Paulo, Sch Vet Med, Dept Pathol, São Paulo, Brazil-
dc.description.affiliationUnespUNESP Univ Estadual Paulista, Inst Biosci, Dept Pharmacol, BR-18618970 São Paulo, Brazil-
dc.description.sponsorshipIdFAPESP: 06/07195-8-
dc.identifier.doi10.1016/j.jep.2011.07.003-
dc.identifier.wosWOS:000295236700097-
dc.rights.accessRightsAcesso aberto-
dc.identifier.fileWOS000295236700097.pdf-
dc.relation.ispartofJournal of Ethnopharmacology-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.